Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Comorbid Dyslexia”

4 trials

Showing 4 of 4 results

Post-approval studies (Phase 4)Study completedNCT00607919
What this trial is testing

Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia

Who this might be right for
Attention Deficit Hyperactivity DisorderDyslexia
Eli Lilly and Company 209
Post-approval studies (Phase 4)Study completedNCT00716274
What this trial is testing

Effects of Atomoxetine on Brain Activation During Attention & Reading Tasks in Participants With ADHD & Comorbid Dyslexia

Who this might be right for
Attention Deficit Hyperactivity DisorderDyslexia
Eli Lilly and Company 110
Post-approval studies (Phase 4)Study completedNCT00191906
What this trial is testing

Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)

Who this might be right for
Attention Deficit Hyperactivity DisorderReading Disorder
Eli Lilly and Company 121
Post-approval studies (Phase 4)Study completedNCT00191048
What this trial is testing

Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD

Who this might be right for
Attention-Deficit/Hyperactivity DisorderComorbid Dyslexia
Eli Lilly and Company 105

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation